Trial Profile
A Longitudinal MRI Study of Changes in Regional Body Composition During Orlistat (60mg)-Assisted Dieting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity; Weight loss
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 12 Jul 2011 New trial record